Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate for Cushing's in ACC
NCT03145285Phase 2Unknown
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Apr 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone in Cushing syndrome, sponsored by ASST Spedali Civili di Brescia. Status: unknown.
02
Drugs
abiraterone
03
Conditions
Cushing syndrome
Beyond the preview
Go deeper on NCT03145285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03145285.